Overall rank by patents
#9,989
of 50,000 tracked assignees
USPTO PatentsView assignee record - 31 granted patents across 22 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
The verdict
According to USPTO PatentsView, Calysta ranks #9,989 of 50,000 tracked US assignees by granted-patent volume, with 31 patents across 22 technology areas.
USPTO PatentsView assignee plate
Corpus R9989 · US Corporation #9,989 · 31 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Cardiac Dimensions Pty. Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
360 Yield Center · near
46 score
Calysta · this assignee
46 score
Crane Payment Innova… · near
46 score
TOYO Denso · near
46 score
Valmet Automation OY · near
46 score
3D Lighting Innovati… · lowest
7 score
What this shows Calysta, Inc. stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-DENSE, TYPE-USCORP, VEL-DOWN, BOOK-FULL. Volume places it #9,989 of 50,000; Innovation Score 45.6/100 sits in the top 23% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Cardiac Dimensions Pty. Ltd. (±0 grants).
Calysta, Inc. has been granted 31 US utility patents between 2016 and 2025, placing Calysta, Inc. at #9,989 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.7 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a US Corporation, Calysta, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Calysta sits between Colormatrix Holdings, Inc. (31 patents, rank #9,998) and Channel Medsystems, Inc. (31 patents, rank #10,006) - the closest US assignees by grant volume. The composite Innovation Score of 45.6/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 14 grants, compared with 16 in the 2015–2019 window, a -12% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Calysta, Inc.'s 23.7 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 22 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
COLORMATRIX HOLDINGS, INC.
31 patents
COMET TECHNOLOGIES USA, INC.
31 patents
CONTROL TECHNIQUES LIMITED
31 patents
CURT Manufacturing, LLC
31 patents
Cardiac Dimensions Pty. Ltd.
31 patents
Cardioxyl Pharmaceuticals, Inc.
31 patents
Celestial AI Inc.
31 patents
Channel Medsystems, Inc.
31 patents
Calysta, Inc.
31 patents
What this shows Calysta holds 31 patents at rank #10,002, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #10,002 in granted patent volume.
Other assignees with the most granted patents in Calysta's primary technology class.
Two PlainPatent-derived peer sets for Calysta, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (46 here).
Calysta's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 23% higher than 77% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 6.5% |
| 2017 | 4 | 12.9% |
| 2018 | 4 | 12.9% |
| 2019 | 6 | 19.4% |
| 2020 | 3 | 9.7% |
| 2021 | 5 | 16.1% |
| 2022 | 2 | 6.5% |
| 2023 | 2 | 6.5% |
| 2024 | 2 | 6.5% |
| 2025partial year | 1 | 3.2% |
Top 15 of 22 technology areas
Overall rank by patents
#9,989
of 50,000 tracked assignees
45.6 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.